111. Congenital myopathy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 13 / Drugs : 37 - (DrugBank : 7) / Drug target genes : 2 - Drug target pathways : 53
| Other names | - | ||
|---|---|---|---|
| Disease group | Neuromuscular diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
405 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 11-23-62. congenital structural myopathy | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 111-1. | Nemaline myopathy; | 11-23-58. nemaline myopathy | |
| 111-2. | Central core disease; | 11-23-59. central core disease | |
| 111-3. | Minicore myopathy; | 11-23-61. mini core disease | |
| 111-4. | Multi-minicore myopathy;Multi-minicore disease; | 11-23-62. congenital structural myopathy | |
| 111-5. | Myotubular myopathy;X-linked myotubular myopathy;XLMTM; | 11-23-56. myotubular myopathy | |
| 111-6. | Centronuclear myopathy;CNM; | 11-23-62. congenital structural myopathy | |
| 111-7. | Congenital fiber-type disproportion myopathy;Congenital fiber-type disproportion; | 11-23-57. Congenital fiber-type disproportion myopathy | |